In our study, we identified a new role of the LOXL4 secreted in TNBC progression: in addition to its traditional collagen cross-linking function, it also targets cancer cell surface annexin A2 as a substrate for enzymatic cross-linking modification. Here, LOXL4 is linked to cancer.